Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

By Cummings Jeffrey L.  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 41-49

Adis International

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Donepezil is better tolerated than rivastigmine in mild-to-moderate Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Metoprolol Tartrate in Patients with Mild-to-Moderate Essential Hypertension: A Randomised, Double-Blind, Multicentre Trial

By Koenig W.  

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 613-619

Adis International

Access to resources Recommend Favorite

Duration of Therapy with Acetylcholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer's Disease as Reported in the Literature

By Melik Razan El   Dubil Amanda   Pound Melanie W.  

The Consultant Pharmacist, Vol. 29, Iss. 6, 2014-06 ,pp. : 400-407

American Society of Consultant Pharmacists

Access to resources Recommend Favorite